Search results
Results from the WOW.Com Content Network
Intraocular lens. An Intraocular lens ( IOL) is a lens implanted in the eye usually as part of a treatment for cataracts or for correcting other vision problems such as short sightedness and long sightedness; a form of refractive surgery. If the natural lens is left in the eye, the IOL is known as phakic, otherwise it is a pseudophakic lens (or ...
The aim of an accurate intraocular lens power calculation is to provide an intraocular lens (IOL) that fits the specific needs and desires of the individual patient. The development of better instrumentation for measuring the eye's axial length (AL) and the use of more precise mathematical formulas to perform the appropriate calculations have significantly improved the accuracy with which the ...
Bausch & Lomb (since 2010 stylized as Bausch + Lomb [2]) is an American-Canadian eye health products company based in Vaughan, Ontario, Canada. It is one of the world's largest suppliers of contact lenses, [3] lens care products, pharmaceuticals, intraocular lenses, and other eye surgery products. [4] [5] The company was founded in Rochester ...
A phakic intraocular lens ( PIOL) is an intraocular lens that is implanted surgically into the eye to correct refractive errors without removing the natural lens (also known as "phakos", hence the term). Intraocular lenses that are implanted into eyes after the eye's natural lens has been removed during cataract surgery are known as pseudophakic.
In 2013, Canadian drugmaker and parent company Bausch Health Companies Inc, previously known as Valeant Pharmaceuticals, bought Bausch + Lomb from Warburg Pincus. Bausch + Lomb to list in U.S. and ...
Term. Feb 2024-. Board member of. Emergent BioSolutions. Children. 3. Joseph C. Papa (born October 1, 1955) is an American businessman and the chairman and chief executive officer (CEO) of Bausch & Lomb, a company formed from the initial public offering (IPO) of the eye health business of Bausch Health Companies Inc. [1]
Bausch & Lomb Ultra, Bausch & Lomb Ultra for Astigmatism, Bausch & Lomb Ultra for Presbyopia Elastofilcon: 0.2: 340: SilSoft Aphakic, SilSoft Super Plus Kalifilcon A 55 134: 0.5: 0.08: Bausch & Lomb INFUSE Asmofilcon A 40 161: 0.9: 0.08: Miru 1month Verofilcon A 51-80 (water gradient) 100 0.6: 0.09: Alcon Precision1, Alcon Precision1 for ...
The firm renamed itself Bushnell Performance Optics. Three years later, Bushnell retired as vice-president of Bausch & Lomb. In 1999, Bausch & Lomb sold Bushnell Performance Optics to the private equity firm Wind Point Partners through a recapitalization of Bushnell's then parent company, Worldwide Sports & Recreation.